Researchers working in the Department of Surgery have published a major new paper in BMC Medicine validating a Cambridge developed more accurate prognostic scoring system for men with new prostate cancer.

This validation study of nearly 75,000 men, confirms that the CPG 5-tiered prognostic model has superior discrimination in predicting prostate cancer death over the contemporary 3-tier model across different age and treatment groups.